M’usa, con l’apostrofo. Le donne di PicassoLetizia Bravi
It’s been over three years since US regulators greenlit the nation’s first in-human test of Crispr’s disease-fighting potential, more than three years of waiting to find out if the much-hyped gene-editing technique could be safely used to beat back tough-to-treat cancers. Today, researchers from the University of Pennsylvania and Stanford finally revealed the first published report describing the trial.
Learn more about your ad choices. Visit podcastchoices.com/adchoices